Company Filing History:
Years Active: 2020
Title: Xiaona Jing - Innovator in Antibody-Drug Conjugates
Introduction
Xiaona Jing is a notable inventor based in Soborg, Denmark. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibody-drug conjugates (ADCs). Her innovative work focuses on improving the formulation and efficacy of these therapeutic agents.
Latest Patents
Xiaona Jing holds a patent for "Lyophilized anti-tissue factor antibody-drug conjugates." This patent discloses surfactant-free lyophilized formulations of ADCs, specifically targeting anti-tissue factor ADCs. The formulations are designed to be particularly suitable for an anti-TF ADC based on an auristatin derivative or other similarly hydrophobic drugs. The excipients used in these formulations typically include histidine, sucrose, trehalose, mannitol, and glycine. She has 1 patent to her name.
Career Highlights
Xiaona Jing is currently employed at Genmab A/S, a leading biotechnology company specializing in the development of innovative antibody therapies. Her work at Genmab has positioned her as a key player in the advancement of ADC technology.
Collaborations
Xiaona collaborates with talented professionals in her field, including Jesper Valbjørn and Kelly Ann Roby. These collaborations enhance the research and development efforts at Genmab, contributing to the company's success in biopharmaceutical innovation.
Conclusion
Xiaona Jing's contributions to the field of antibody-drug conjugates exemplify her commitment to advancing biopharmaceutical technology. Her innovative formulations and collaborative efforts continue to impact the industry positively.